SEC Form 4 · accession 0001437749-17-015344
BioCardia, Inc. · BCDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Quertermous
Director
Period of report
Jun 15, 2017
Accepted (ET)
Aug 25, 2017 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000925741
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $0.40 | Jun 15, 2017 | A | 156,583 | A | — | Jun 15, 2027 | Common Stock | 156,583 | 156,583 | D |
Explanation of responses
- F1One hundred percent of the shares subject to the option vest and become exercisable on the one year anniversary of the date of grant.